USPTO serial 79291076
HF-DEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 16, 2021
- Examiner
- KUNKLEMAN, SARAH E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HF-DEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | scientific and measuring apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus; scientific and measuring instruments to monitor for heart failure, heart disease, heart irregularities, organ failure or disease being activity trackers, Downloadable Software as a Medical Device (SaMD) for diagnosing heart arrhythmia, fluid levels in humans or animals including in human or animal intracellular or extracellular fluid levels, measuring the composition of body fluids; mobile data apparatus and instruments, namely, mobile data receivers; mobile telephones; data processing equipment, namely, couplers; computers; downloadable computer programs and computer software for bioelectrical impedance measuring and recording, to operate bioimpedance analysis instruments and bioimpedance spectroscopy instruments, to record bodily functions, heart rate, biomass, body composition, cell composition and to record and process bioimpedance data; downloadable software applications for bioelectrical impedance measuring and recording, to operate bioimpedance analysis instruments and bioimpedance spectroscopy instruments, to record bodily functions, heart rate, biomass, body composition, cell composition and to record and process bioimpedance data; non-medical meters for measuring electrical current through humans; spectroscopes; non-medical devices for scientific use in measuring the composition of body fluids; telecommunications apparatus in the nature of wireless transmitters and receivers; communication devices, namely, cellphones and wireless communication devices for voice, data, and image transmission; monitoring apparatus, namely, alarm monitoring systems; apparatus for alarm signalling and receiving alerts, namely, alarm installations and alarms; emergency call telephone apparatus in the nature of a telephone terminal; non-medical sensors for measuring physical movements of a patient wearing or carrying the device, namely, sensor chips for scientific use; data processing equipment, namely, interface cards for data processing equipment in the form of printed circuits and computer hardware in the nature of central processing units; downloadable computer programs and software for data measurement, data transformation, data storage, patient tracking, results interpretation, results analysis, and results display for application to bioimpedance readings generated by a bioimpedance analysis instrument or bioimpedance spectroscopy instrument; scientific and measuring apparatus and instruments for measuring and recording hydration, fluid density and retention in humans and animals; scientific and measuring apparatus and instruments for measuring and recording fluid levels in humans, animals, namely, extracellular fluid in human limbs; laboratory and scientific apparatus for use in testing, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific apparatus for diagnostic testing of biological samples, other than for medical use, namely, electronic analyzers for measuring, testing and analyzing blood and other bodily fluids; testing apparatus, not for medical purposes, namely, semiconductor testing apparatus; downloadable software for remote control and operation of scientific and measuring apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus and instruments; bio-sensors, namely, sensors that gather human biometric data and sensor chips, all for scientific use; test electrodes, other than for medical use; non-medical scientific measuring instruments for recording activity, size and performance of human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands, namely, to record fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; alarm signalling and receiving apparatus and alarm devices, other than for vehicles, namely, non-medical alarm sensors to monitor for heart failure, heart disease, heart irregularities, organ failure or disease and to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs in particular to fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; replacement and structural parts for use with all of the foregoing | ACTIVE | — |
| 010 | medical and veterinary apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus and instruments and accessories for estimating the composition of living matter; bioelectrical impedance analysis or bioimpedance spectroscopy devices for medical purposes; medical diagnostic testing apparatus, for testing for heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs in particular fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands; medical apparatus for the diagnosis and treatment of lymphoedema; medical spectroscopes; meters for body fluids for medical use; implantable devices for medical use in measuring the composition of body fluids; medical or veterinary meters for measuring electrical current passing through humans, animals; devices for medical and veterinary use, namely, instruments for use in clinical applications for determining body composition, segmental body composition, fluid level measurements, lymphedema assessment, detection and measurement, unilateral and bilateral, measurement, all in human or animal subjects; devices for medical and veterinary use, namely, instruments for use in clinical applications for determining hydration, measuring and recording fluid in humans, animals, namely, extracellular fluid in human limbs; consumable electrodes for medical use, electrodes for medical purposes, electrodes for picking up biological parameters for medical use, electrodes for use with medical apparatus, electrophysiology electrodes for medical use; medical electrodes; medical and veterinary apparatus and instruments for monitoring and recording activity, size and performance of human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands, in particular to record fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands; medical alarm and monitoring devices to monitor for heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs, in particular, to heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; electronic devices for assisting care giving for seniors or people needing assistance comprised of sensors for determining status of person and apparatus for sending electronic alerts to care givers, namely, sensors that gather human biometric data and sensor chips and also including wireless transmitters and receivers sold as a unit, all for medical use; medical products, namely, biofeedback sensors in the nature of electronic sensors to monitor people's health including monitoring for heart failure, heart disease, heart irregularities, organ failure or disease and monitoring human vital signs, namely, fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands and to notify the wearer and third parties in relation to data relating to those human vital signs; replacement and structural parts for use with all of the foregoing | ACTIVE | — |
| 044 | medical services; veterinary services; medical health assessment services; provision of health care services, namely, geriatric health care, cardiology services, pulmonary services, and endocrinology services; medical analysis services for diagnostic and testing purposes provided by medical laboratories; bioimpedance testing of human or animal subjects in the nature of medical testing for diagnostic or treatment purposes; analysing body composition in human and/or animal subjects, namely, medical body composition analysis services; testing and analysis of segmental body composition, hydration, fluid level measurements, lymphedema assessment, detection and measurement, unilateral and bilateral, namely, in human or animal subjects and particularly using bioimpedance in the nature of medical testing for diagnostic or treatment purposes; fitness testing being health assessments services; medical blood testing services; all of the foregoing including those provided remotely or online; medical services, namely, services to monitor for heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor, intervene and recommend treatment in relation to disease, ill-health, lymphedema or identified patient symptoms of any kind and including such services provided by software or otherwise not requiring human intervention; provision of information in relation to all of the foregoing; advisory and consultancy services in relation to the foregoing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Impedimed Limited
- Other trademarks owned by Impedimed Limited
- Other trademarks owned by Impedimed Limited
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named HF-DEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 4, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 16, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 31, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 31, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 11, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 11, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 11, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 27, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 27, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 27, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 27, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 5, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 5, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 5, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 9, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 9, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 9, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 9, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 23, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Dec 18, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Oct 16, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 11, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |